EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Using the EQ-5D to measure caregiver health-related quality of life in rare pediatric disease: a study in aromatic L-amino acid decarboxylase deficiency

Sarah Acaster, Kate Williams, Hanna Skrobanski, Katharina Buesch

Future Neurology · 16.06.2022 · 17 (2)

DOI: 10.2217/fnl-2022-0004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Future Neurology, online erschienen am 16.06.2022. Verfasst von Sarah Acaster und 3 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: PTC Therapeutics International Ltd..

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To evaluate how well the EQ-5D-5L, a generic preference-based measure of health-related quality of life, captures caregiver burden in a rare pediatric neurotransmitter disease. Materials & methods: Caregivers (n = 14) of individuals with aromatic L-amino acid decarboxylase (AADC) deficiency completed qualitative interviews on their experience as a caregiver, the EQ-5D-5L and a background questionnaire. Qualitative and quantitative data were compared to determine whether there was concordance or discordance in the findings.

Results

No caregivers reported problems with mobility and self-care in either the qualitative interviews or on the EQ-5D-5L, and there was general concordance for pain/discomfort and anxiety/depression. However, discordance was found for usual activities, with 79% reporting no problems with this dimension on the EQ-5D-5L, compared with 100% describing substantial limitations during the interviews.

Conclusion

The EQ-5D-5L may not be appropriate to evaluate caregiver burden in AADC deficiency, where caregivers' perceptions of “usual activities” differ substantially from the general population.

Förderung

  • PTC Therapeutics International Ltd.

Zitieren

APA

Acaster, S., Williams, K., Skrobanski, H., & Buesch, K. (2022). Using the EQ-5D to measure caregiver health-related quality of life in rare pediatric disease: a study in aromatic L-amino acid decarboxylase deficiency. Future Neurology, 17(2). https://doi.org/10.2217/fnl-2022-0004

Vancouver

Acaster S, Williams K, Skrobanski H, Buesch K. Using the EQ-5D to measure caregiver health-related quality of life in rare pediatric disease: a study in aromatic L-amino acid decarboxylase deficiency. Future Neurology. 2022;17(2). doi:10.2217/fnl-2022-0004

BibTeX
@article{Acaster2022,
  author = {Acaster, Sarah and Williams, Kate and Skrobanski, Hanna and Buesch, Katharina},
  title = {Using the EQ-5D to measure caregiver health-related quality of life in rare pediatric disease: a study in aromatic L-amino acid decarboxylase deficiency},
  journal = {Future Neurology},
  year = {2022},
  volume = {17},
  number = {2},
  doi = {10.2217/fnl-2022-0004}
}
Kostenlos starten →